Xin Lang Cai Jing·2026-03-27 23:40Core Viewpoint - The application for potassium chloride granules by Shandong Xinhua Pharmaceutical Co., Ltd. has been accepted, with the acceptance number CYHB2600620, on March 28, 2026 [1][4]. Company Information - Shandong Xinhua Pharmaceutical Co., Ltd. was established on November 20, 1998, and is a large-scale company in the chemical pharmaceutical raw material manufacturing industry [2][5]. - The legal representative is He Tongqing, and the company is located at No. 13, Chemical Road, Chemical Industry Development Zone, Zibo City [2][5]. - The company has a registered capital of 6,897.76535 million RMB and an actual paid-in capital of 6,897.76535 million RMB, with 4,753 insured employees [2][5]. Shareholder Information - Major shareholders include: - Hualu Holding Group Co., Ltd. with a 29.7% stake and a subscribed capital contribution of 204,864,092 RMB [2][5]. - Hong Kong Central Clearing Limited (agent) with a 28.05% stake and a subscribed capital contribution of 193,516,187 RMB [2][5]. - Hualu Investment Development Co., Ltd. with a 5.38% stake and a subscribed capital contribution of 37,091,988 RMB [2][5]. - Other shareholders include Hong Kong Central Clearing Co., Ltd. and China Merchants Bank Co., Ltd. with smaller stakes [2][5].